Precipio (NASDAQ:PRPO) is launching its fast COVID-19 antibody take a look at on the market on Amazon (NASDAQ:AMZN) and its inventory is hovering on the information. Nevertheless, it’s not only a case of anybody should buy it.
Let’s check out every part you have to know concerning the fast novel coronavirus testing coming to Amazon.
- The providing from Precipio exams for each IgG & IgM antibodies.
- It’s additionally capable of flip in ends in as quick as 20 minutes.
- Along with that, this was the primary US-based take a look at to obtain emergency use authorization by the U.S. Meals and Drug Administration (FDA) for point-of-care.
- Clients are capable of see the coronavirus take a look at on Amazon’s web site.
- Regardless of this, not simply anybody should purchase it.
- The sale of the take a look at is barely out there to certified medical point-of-care suppliers.
- Meaning the common prospects can simply go purchase one of many coronavirus exams for themselves.
- Nevertheless, the itemizing does promise two-day transport for these which are capable of buy it.
- The testing package on Amazon contains “25 take a look at playing cards, 25 lancets and 25 capillary tubes, in addition to a bottle of buffer liquid enough for 25 exams.”
- It’s additionally price mentioning that these exams don’t require any laboratory tools.
- Precipio has unique rights to promote these coronavirus exams on Amazon.
- The exams are made by Nirmidas Biotech, which is predicated out of California.
Ilan Danieli, CEO of Precipio, stated this concerning the information sending PRPO inventory increased as we speak.
“We’re very excited to be working with our accomplice Nirmidas to get this essential fast take a look at on the biggest retail platform on the planet. We look ahead to working with different stores, in addition to with Nirmidas to advance this product into at-home use, following the receipt of acceptable FDA authorization.”
PRPO inventory was up 91.2% as of Monday afternoon.
Precipio isn’t the one firm making coronavirus information these days.
Different firms are additionally offering updates on coronavirus information that buyers will wish to notice. That features Valneva, Ocugen (NASDAQ:OCGN), and Bionano Genomics (NASDAQ:BNGO). Buyers can be taught extra on the following hyperlinks!
Extra Coronavirus Information
On the date of publication, William White didn’t have (both straight or not directly) any positions within the securities talked about on this article.
With solely the rarest exceptions, InvestorPlace doesn’t publish commentary about firms which have a market cap of lower than $100 million or commerce lower than 100,000 shares every day. That’s as a result of these “penny shares” are ceaselessly the playground for rip-off artists and market manipulators. If we ever do publish commentary on a low-volume inventory which may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this truth and warn readers of the dangers. Learn Extra: Penny Shares — Methods to Revenue With out Getting Scammed
Article printed from InvestorPlace Media, https://investorplace.com/2021/05/prpo-stock-12-things-to-know-about-the-precipio-rapid-covid-19-antibody-test-launch-on-amazon/.
©2021 InvestorPlace Media, LLC